Page 7 - Commercializing Hardtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Commercializing hardtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Commercializing Hardtech Today - Breaking & Trending Today

GenSight Biologics S A : Announces the Filing of its 2022 Universal Registration Document and Reschedules its Annual General Meeting on June 21, 2023

Paris, France, Wednesday May 10, 2023, 6:00 pm CEST - GenSight Biologics , a biopharma company focused on developing and commercializing innovative gene therapies for retinal. | May 10, 2023 ....

France General , Gensight Biologics , Gensight Biologics Euronext , Thomas Gidoin , Bernard Gilly , Wednesday May , Sight Biologics , Registration Document , Des March , Scientific Advice , Chief Executive Officer , Chief Financial Officer , Annual General Meeting , Gensight Biologics Sa Stock Exchange , Press Release , Or Sight Fr0013183985 ,

Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry

MENLO PARK, Calif., May 06, 2023 Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology that enables procedures intended to improve. | May 6, 2023 ....

San Diego , United States , Stanford University , Philip Taylor , Michael Mbagwu , Carmen Caricchio , Stanford University School Of Medicine , American Academy Of Ophthalmology , Intelligent Research In Sight , American Society Of Cataract , American Academy Of Neurology , Globenewswire Inc , Verana Health , Sight Sciences Inc , Gilmartin Group , Sight Sciences , Hm Group , Verana Health Qdata , American Urological Association , Surgical System , Clinical Registry Study , Glaucoma Medication Use , Mild Glaucoma Severity After , Adjunct Clinical Instructor , University School , Senior Medical Director ,

INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference

PLYMOUTH MEETING, Pa., May 5, 2023 /PRNewswire/ INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related. | May 5, 2023 ....

Thomas Hong , Jacqueline Shea , Jennie Willson , Pharmaceuticals Inc , Markets Global Healthcare , Relations Events , Inovio Pharmaceuticals , Nc Stock Exchange , Press Release , Rom Ino Us45773h2013 ,

Soligenix Announces Pricing of $8.5 Million Public Offering

PRINCETON, N.J., May 5, 2023 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an. | May 5, 2023 ....

New York , United States , Us Congress , National Institute Of Allergy , Biomedical Advanced Research , Prnewswire Soligenix Inc , Defense Threat Reduction Agency , Us Development , Development Authority , Our Public Health Solutions , Soligenix Inc , A Gp Alliance Global Partners , Exchange Commission , Alliance Global Partners , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher , Nc Stock Exchange , Press Release , S Sngx Us8342235053 ,

Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 04, 2023 Galera Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that. | May 4, 2023 ....

United States , William Windham , Christopher Degnan , Zara Lockshin , Compensation Committee Of Galera , Solebury Strategic Communications , Exchange Commission , Galera Therapeutics Inc , Drug Administration , Compensation Committee , Galera Therapeutics , Inducement Award Plan , Inducement Plan , Nasdaq Listing Rule , New Drug Application , Prescription Drug User Fee , Private Securities Litigation Reform Act , Breakthrough Therapy Designation , Fast Track Designation , Annual Report , Nc Stock Exchange , Press Release , Herapeutics Grtx Us36338d1081 ,